Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Neglected side effects to curative prostate cancer treatments

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. A model for digital innovations in sexual medicine

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. A qualitative analysis of Internet forum discussions on hard flaccid syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Standardized reporting for sexual function following prostate cancer treatment

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  4. Consulting "Dr Google" for sexual dysfunction: a contemporary worldwide trend analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Evaluation of a re-engineered device for penile vibratory stimulation in men with spinal cord injury

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Udredning og behandling af mandlig infertilitet

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. A model for digital innovations in sexual medicine

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Vis graf over relationer

In this narrative review we summarize neglected side effects of curative intended treatment for prostate cancer. They include climacturia, arousal incontinence (AI), orgasmic disturbances such as altered orgasmic sensation, anorgasmia, and orgasm-associated pain (dysorgasmia), ejaculatory dysfunction, and morphological penile alterations in the form of shortening and deformity. Even though they have not received as much interest as erectile dysfunction (ED) or urinary incontinence, these side effects have been shown to negatively impact patient's quality of life. They are common and rates of climacturia after radical prostatectomy (RP) range from 20% and 45%, less after external beam radiation therapy (EBRT). Decreased orgasmic sensation ranges from 3.9% to 60% after RP and between 36-57% after EBRT. Dysorgasmia ranges from 9.5-15% for both RP and EBRT. Anejculation after EBRT ranges from 11-71% and rates of penile shortening are reported between 0 and 100%. There are no internationally validated questionnaires that adequately asses these side effects. This is necessary if we are to align patient and partner expectations properly and consequently manage them optimally. Neglected side effects should be discussed with patients and their partners preoperatively, as they are associated with bother and may lead to patient's avoiding sexual activity.

OriginalsprogEngelsk
TidsskriftInternational Journal of Impotence Research
ISSN0955-9930
DOI
StatusE-pub ahead of print - 14 dec. 2020

ID: 61825358